Cardiovascular Benefits

3 min · 5 de mar de 2024

Descripción

* FDA Indications * Clinical Trial Evidence

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Clinical Questions in Cardiology: Using Glucagon-like Peptide-1 Receptor Agonists!

7 episodios

Cardiologist Collaboration

Role in Diabetes Management Multidisciplinary Team-based Approach

Individualizing Therapy

Drug Initiation and Monitoring Contraindications and Adverse Effects Patient Education

Cardiovascular Benefits

* FDA Indications * Clinical Trial Evidence

Glycemic/Non-Glycemic Effects

Short-Acting versus Long-Acting Agents Fasting and Postprandial Blood Glucose Gastric Emptying and Body Weight

Pathophysiologic Targets

Diabetes Pathophysiology Glucagon-Like Peptide-1 Mechanisms